<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Le VTT</submitter><funding>Ministry of Education and Training</funding><funding>This research was funded by the Ministry of Education and Training under the Ministry of Sci-ence and Technology Project</funding><pagination>7253</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10650832</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>28(21)</volume><pubmed_abstract>The results of in silico screening of the 50 isolated compounds from &lt;i>Millettia dielsiana&lt;/i> against the target proteins PDE4 (PDE4A, PDE4B, and PDE4D) showed binding affinity ranges from -5.81 to -11.56, -5.27 to -13.01, and -5.80 to -12.12 kcal mol&lt;sup>-1&lt;/sup>, respectively, with median values of -8.83, -8.84, and -8.645 kcal mol&lt;sup>-1&lt;/sup>, respectively. Among these compounds, Millesianin F was identified as the most promising PDE4A inhibitor due to its strongest binding affinity with the target protein PDE4A. (-11.56 kcal mol&lt;sup>-1&lt;/sup>). This was followed by the compound 5,7,4'-trihydroxyisoflavone 7-&lt;i>O-β&lt;/i>-d-apiofuranosyl-(1→6)-β-d-glucopyranoside (D50) with the binding affinity value of -11.35 kcal mol&lt;sup>-1&lt;/sup>. For the target protein PDE4B, compound D50 exhibited th</pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pubmed_title>Natural Phosphodiesterase-4 Inhibitors with Potential &lt;i>Anti&lt;/i>-Inflammatory Activities from &lt;i>Millettia dielsiana&lt;/i>.</pubmed_title><pmcid>PMC10650832</pmcid><funding_grant_id>B2021-TNA-19</funding_grant_id><funding_grant_id>Code: B2021-TNA-19</funding_grant_id><pubmed_authors>Le VTT</pubmed_authors><pubmed_authors>Le CH</pubmed_authors><pubmed_authors>Lam DT</pubmed_authors><pubmed_authors>Ha NX</pubmed_authors><pubmed_authors>Hung HV</pubmed_authors><pubmed_authors>Minh PTH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Natural Phosphodiesterase-4 Inhibitors with Potential &lt;i>Anti&lt;/i>-Inflammatory Activities from &lt;i>Millettia dielsiana&lt;/i>.</name><description>The results of in silico screening of the 50 isolated compounds from &lt;i>Millettia dielsiana&lt;/i> against the target proteins PDE4 (PDE4A, PDE4B, and PDE4D) showed binding affinity ranges from -5.81 to -11.56, -5.27 to -13.01, and -5.80 to -12.12 kcal mol&lt;sup>-1&lt;/sup>, respectively, with median values of -8.83, -8.84, and -8.645 kcal mol&lt;sup>-1&lt;/sup>, respectively. Among these compounds, Millesianin F was identified as the most promising PDE4A inhibitor due to its strongest binding affinity with the target protein PDE4A. (-11.56 kcal mol&lt;sup>-1&lt;/sup>). This was followed by the compound 5,7,4'-trihydroxyisoflavone 7-&lt;i>O-β&lt;/i>-d-apiofuranosyl-(1→6)-β-d-glucopyranoside (D50) with the binding affinity value of -11.35 kcal mol&lt;sup>-1&lt;/sup>. For the target protein PDE4B, compound D50 exhibited th</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Oct</publication><modification>2026-04-08T13:16:53.979Z</modification><creation>2024-12-04T10:17:48.864Z</creation></dates><accession>S-EPMC10650832</accession><cross_references><pubmed>37959674</pubmed><doi>10.3390/molecules28217253</doi></cross_references></HashMap>